导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.29% | 916/1050 |
| 近一周 | -2.69% | 693/1104 |
| 近一月 | -5.45% | 654/1102 |
| 近一季 | -15.88% | 861/1092 |
| 近半年 | -19.95% | 986/1070 |
| 近一年 | -12.92% | 777/1018 |
| 近两年 | 17.96% | 791/926 |
| 近三年 | 6.55% | 616/834 |
| 成立以来 | 211.17% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.41% 776/1070 |
11.83% 522/1101 |
- - |
- - |
| 2025 | 30.56% 465/1065 |
-2.63% 936/1014 |
4.09% 356/1038 |
33.35% 311/1050 |
-3.40% 627/1065 |
| 2024 | 0.93% 554/1011 |
7.91% 51/960 |
0.52% 270/983 |
1.82% 941/991 |
-8.62% 851/1011 |
| 2023 | -4.94% 200/952 |
3.11% 439/880 |
-3.76% 432/895 |
-1.54% 138/915 |
-2.71% 294/952 |
| 2022 | -23.16% 444/867 |
-14.94% 258/773 |
11.62% 203/806 |
-10.98% 301/845 |
-9.08% 762/867 |
| 2021 | 11.87% 219/740 |
-0.05% 154/580 |
10.61% 340/659 |
2.79% 170/704 |
-1.56% 498/740 |
| 2020 | 75.69% 112/554 |
-4.97% 287/419 |
26.42% 176/466 |
17.06% 100/517 |
24.92% 68/554 |
| 2019 | 48.48% 160/410 |
23.72% 800/1149 |
-4.58% 679/1231 |
9.15% 127/390 |
15.24% 51/410 |
| 2018 | -18.74% 55/349 |
- - |
- - |
- - |
-9.10% 222/1080 |
| 2017 | 14.04% 117/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 博时丝路主题股票C VS. 东吴新产业精选股票A(580008) |